Cybin (HELP) Change in Receivables (2020 - 2025)
Cybin (HELP) reported Change in Receivables of -$210468.8 for Q1 2025, down 28.91% on a YoY basis from -$296069.8 in Q1 2024, and down 105.27% quarter-over-quarter from $4.0 million in Q4 2024.
Cybin (HELP) Change in Receivables (2020 - 2025) Analysis & Trends
Cybin has reported Change in Receivables for 6 years, with the latest figure at -$210468.8 in Q1 2025.
- For the quarter ending Q1 2025, Change in Receivables fell 28.91% year-over-year to -$210468.8; the trailing twelve-month figure through Mar 2025 stood at -$899151.9 (down 11.21% YoY), and the FY2025 full-year result was -$1.0 million, down 25.42% from the prior year.
- Change in Receivables for Q1 2025 stood at -$210468.8, down from $4.0 million in the prior quarter.
- The five-year high for Change in Receivables was $4.0 million in Q3 2024, with the low at -$481412.0 in Q3 2021.
- Historically, Change in Receivables has averaged $654710.6 across 5 years, with a median of -$168674.9 in 2023.
- Annual changes were most pronounced in 2021 — Change in Receivables plunged 306.03% — and 2024, when it soared 2917.64%.
- Cybin's Change in Receivables stood at $90440.3 in 2021, then jumped by 97.13% to $178282.1 in 2022, then slumped by 197.65% to -$174084.9 in 2023, then surged by 2395.77% to $4.0 million in 2024, then sank by 105.27% to -$210468.8 in 2025.
- The last three Change in Receivables figures came in at -$210468.8 (Q1 2025), $4.0 million (Q4 2024), and $4.0 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -210,468.78 |
| Mar 31, 2025 | -210,468.78 |
| Dec 31, 2024 | 4.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.04 Mn |
| Sep 30, 2024 | 4.04 Mn |
| Jun 30, 2024 | 3.38 Mn |
| Jun 30, 2024 | 3.38 Mn |
| Mar 31, 2024 | -163,264.91 |
| Mar 31, 2024 | -163,264.91 |
| Dec 31, 2023 | -174,084.92 |
| Dec 31, 2023 | -174,084.92 |
| Sep 30, 2023 | -351,333.25 |
| Sep 30, 2023 | -351,333.25 |
| Jun 30, 2023 | -119,856.85 |
| Jun 30, 2023 | -119,856.85 |
| Dec 31, 2022 | 178,282.11 |
| Dec 31, 2022 | 178,282.11 |
| Sep 30, 2022 | -440,879.09 |
| Sep 30, 2022 | -440,879.09 |